China's Ministry of Commerce issued a formal Q&A response on 29 September 2026 after EU member states began drafting a joint document calling for a European trade enforcement mechanism modelled on the US Section 301 tool.
From $9/month · 7-day free trial
Already a subscriber? Log in
Subscribe for full access to all articles
Start Free Trial
A seven-ministry battery policy directive sets a 2030 target for preliminary commercialisation of all-solid-state batteries and a PPB-level defect rate at leading enterprises.
Three simultaneous developments — a new Five-Year Plan, a $2.9 billion Series A record, and the world's first AI-designed drug entering Phase III — mark a structural shift in China's pharmaceutical industry. CITIC Securities assessed 2026 as the most commercially certain year yet for AI healthcare.
China's 15th Five-Year Plan for batteries sets 2030 as the target year for preliminary large-scale deployment of all-solid-state batteries, with leading manufacturers required to reach parts-per-billion defect rates.